Science

Regenerative medicine

Japanese commercialization drive in full swing

TOKYO -- Regenerative medicine in Japan has shifted into high gear, with the domestic market projected to balloon into a 2.5 trillion yen industry ($20.7 billion) by 2050. Japan is a research leader in the field, which focuses on treatments that ...

  • Next-gen drug development

    Takeda, Kyoto University team on iPS cell research

    TOKYO -- Kyoto University and Takeda Pharmaceutical will pursue joint research using induced pluripotent stem cells, or iPS cells, with the aim of developing treatments for such common illnesses as heart disease and diabetes. The Japanese drugmak...

  • Counterfeit medicine

    Beware of Medicrimes, warn Asian pharmaceutical associations

    Tokyo -- People in Asia are at more risk of consuming counterfeit medicine than anywhere else, according to a participant of the 4th Asia Partnership Conference of Pharmaceutical Associations held in Tokyo on Thursday. "A lot of medicrimes are ha...

  • iPS cells

    Japanese inventor eyes patent cross-licensing with US supplier

    OSAKA -- Nobel laureate Shinya Yamanaka wants to work more closely on stem cell technology with a U.S. bioventure soon to be acquired by Japan's Fujifilm Holdings, he told The Nikkei on Wednesday. A deeper partnership between them could help prov...

  • Promise of iPS cells

    Japan, South Korea hospitals plan joint research

    TOKYO -- Private hospital operators in Japan and South Korea have agreed to cooperate in the field of regenerative medicine in areas ranging from education to research to clinical application. Osamu Otsubo, chairman of Otsubo Medical, and Cha Kwa...

  • Riken's fresh face

    New chief at Japanese research center calls for reform

    TOKYO -- Riken, Japan's premier research organization, will turn to young talent as it seeks to regain its shine in the wake of a scandal over now-retracted stem cell studies, a new president says. Hiroshi Matsumoto took the helm at Riken last We...

  • Turning CO2 into fuel

    How artificial photosynthesis could cut emissions

    TOKYO -- In recent years, two Japanese electronics makers have made big advances in artificial photosynthesis research. With the help of government funding, companies and universities are hoping to develop the artificial photosynthesis technology...

  • Chinese medical research

    Advanced lab to study Ebola, other virulent diseases

    BEIJING -- China will by the end of this year open an advanced laboratory for developing ways to diagnose and treat virulent infectious diseases, such as Ebola and smallpox. The center, in Wuhan, Hubei Province, will be a so-called biosafety leve...

  • Possible breakthrough

    Japan-US team claims progress on Ebola vaccine

    TOKYO -- A Japanese-U.S. team said it has developed a new vaccine against Ebola that can prevent the deadly disease in monkeys exposed to dangerous levels of the virus. University of Tokyo virologist Yoshihiro Kawaoka and his team, which includes...

  • Regenerative medicine

    Riken will tap iPS cell bank for transplant

    OSAKA -- A stockpile of stem cells derived from other people will be used in clinical trials of cell transplants for patients with an incurable eye disease, a potential breakthrough that could sharply reduce costs and waiting time. Masayo Takahas...

  • Muscular dystrophy

    Japan makes strides toward stem cell therapy

    OSAKA -- Japanese researchers report taking their first steps toward possible stem-cell-based treatments for muscular dystrophy. A Kyoto University team and chemical company Asahi Kasei created skeletal muscle stem cells from induced pluripotent ...

  • Stem cells

    Japanese team sees progress on treating kidney failure

    OSAKA -- A research team at Kyoto University and Astellas Pharma has treated acute kidney failure with some success by using induced pluripotent stem cells, The Nikkei learned Friday. The group led by professor Kenji Nagafune at Kyoto University'...

  • Nobel winner Noyori to resign as Riken head after stem cell scandal

    TOKYO (Kyodo) -- Ryoji Noyori, a Japanese Nobel laureate who heads the Riken research institute, intends to step down after a difficult year caused by a Riken researcher's misconduct in a stem-cell study, sources close to the matter said Friday. ...

  • Kyoto Univ. Hospital to open iPS cell therapy center in 2019

    KYOTO (Kyodo) -- Kyoto University Hospital will open a center to conduct clinical studies on induced pluripotent stem cell therapies in the 2019 financial year, the hospital said Monday. According to the hospital, the 30-bed ward will test the ef...

  • Drug-resistant malaria

    Experts warn of disease's deadly spread in Asia

    As virulent, drug-resistant strains of malaria spread in Asia, governments in the Asia-Pacific region must redouble their efforts to eradicate the disease, amid the growing risk that these new forms will spread to South Asia, China and Africa, accord...

  • Useful nematodes

    Hitachi harnessing roundworms to sniff out cancer

    TOKYO -- Hitachi and Kyushu University plan to develop a low-cost test that detects cancer by exploiting how roundworms react to the urine of people with the disease. Roundworms measure about 1mm long and are attracted to the smell of cancer pati...

  • Not off the hook

    Japanese institute may pursue charges against disgraced biologist

    OSAKA -- The Riken research institute may file a criminal complaint against an ex-staffer accused of scientific misconduct and charge her for the expense of discredited stem cell studies. Haruko Obokata resigned last December, but the government-...

  • Biotech breakthroughs

    Synthetic biology puts artificial organisms within reach

    TOKYO -- Researchers in Japan are taking bioscience to new limits, creating artificial organisms that can generate a range of useful substances more efficiently and with greater functions. Such organisms could bring revolutionary changes to manufactu...

  • A new dawn

    Japan's Akatsuki probe to attempt Venus orbit again

    TOKYO -- A Japanese space probe launched five years ago will on Dec. 7 try for the second and possibly final time to get into orbit around Venus, the Japan Aerospace Exploration Agency announced Friday. Akatsuki, meaning "dawn" in Japanese, was d...

  • New biodrug class

    Japanese companies off to fast start in nucleic acid treatments

    TOKYO -- Japan's pharmaceutical industry has been quick off the blocks in the new field of nucleic acid medicine, not wanting to repeat their slow showing in the market for antibody drugs. Nucleic acid medicines are a new class of biopharmaceutic...